ArticleDer Nervenarzt2026
[Current opioid consumption among younger patients : A comparison between the years 2019 and 2023 in a large addiction clinic in Hamburg].
Article in Der Nervenarzt, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIt remains unclear whether an opioid crisis similar to that in the United States can be expected in Germany. In September 2024, the federal government stated that it does not see any danger of this occurring in the country. Nevertheless, the number of drug-related deaths in 2023 reached an all-time high of 2227 victims, with opioids involved in 1626 of those cases. For a more comprehensive assessment, information from additional settings may be helpful.
objectivesThis study aimed to analyze the quantitative development of inpatient treatment cases of younger patients with opioid addiction from a large addiction clinic in Hamburg, as well as their consumption patterns. MATERIALS AND
methodsBased on data stored in electronic patient records, a comparison was made of the relative proportions of inpatient patients treated for opioid addiction in the age groups "18-30 years" vs. "≥ 31 years" between the years 2019 and 2023 using chi-square tests. Additionally, the substances consumed were analyzed.
resultsA significant increase in the relative proportion of young opioid-dependent patients was observed, rising from 17.2% in 2019 to 27.5% in 2023 (p < 0.001). Heroin remained the most commonly consumed substance, consistently inhaled or taken nasally. The use of oxycodone increased significantly. Additionally, a significant increase in pregabalin consumption was noted.
conclusionsAlthough the collected data may not be representative of Germany as a whole, our study suggests a growing issue with opioid addiction. Possible causes may include psychological stress, potentially influenced by the aftermath of the COVID-19 pandemic. The results highlight the need for more comprehensive treatment options and preventive measures.
Indexed as
Identifiers
40379792What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.